Abstract:Back in the year 2009, we presented in this journal a neonate with an unusual combination of congenital lactic acidosis and bilateral calcifications in the adrenal medulla 1 . After prenatal ultrasound examination at 21 weeks had revealed intrauterine growth retardation and pericardial effusions, labor was induced at 38 weeks of pregnancy. The patient was hypotonic at birth, had respiratory insufficiency necessitating intubation and artificial ventilation, hepatomegaly and severe cardiomegaly. Intensive care was withdrawn in accordance with parents' wishes on day 38. At the time, the patient's causal genetic defect had remained unknown, yet clinical and biochemical evidence ticked all the boxes of an underlying mitochondrial defect. Postmortem spectrophotometric evaluation then revealed decreased oxidative phosphorylation activities in heart muscle (complex IV) and liver (complexes I, III, IV and V), and normal activities in skeletal muscle and cultured skin fibroblasts. Blue-native polyacrylamide gel electrophoresis of liver extracts confirmed decreased activities of complexes III and IV and showed the presence of subcomplexes of complex V. Thanks to the great genetic leap forward taken by medical research ever since, we were now able to thoroughly investigate the patient's whole exome extracted from preserved cultured skin fibroblasts. These investigations picked up compound heterozygous missense variants in the gene encoding the mitochondrial leucyl-tRNA synthetase ( LARS2 ): c.302 A > G (p.His101Arg) and c.516 G > T (p.Arg172Ser). Nuclear-encoded mitochondrion-specific aminoacyl-tRNA synthetases exist for 17 of the 20 proteogenic amino acids, and pathogenic mutations have now been reported for each one of these 2 . At the time we published our casus, LARS2 defects had not been reported, yet between the year 2013 and now, a total of 23 patients have been described that carry disease-causing LARS2 variants (Table 1) 1,3,4,5,6,7,8,9,10,11,12,13 . Their diverse associated disease phenotypes, which include Perrault syndrome, multisystem disease, leukodystrophy and intellectual disability, do not appear to have an obvious link with genotype. With the casus we presented in this journal and now have characterized at the molecular level, more than twenty patients with 18 unique combinations of disease-causing LARS2 variants have been reported so far, only one was homozygous the others concerned compound heterozygous variants. Table 1 Published patients carrying disease-causing LARS2 variants. Full size table

Recurrent acute liver failure in alanyl-tRNA synthetase-1 (AARS1) deficiency

Compound Heterozygous Variations in IARS1 Cause Recurrent Liver Failure and Growth Retardation in a Chinese Patient: a Case Report

Two siblings with acute necrotizing encephalopathy associated with variants of LARS1

Instability of the mitochondrial alanyl-tRNA synthetase underlies fatal infantile-onset cardiomyopathy

Expanded phenotype of AARS1-related white matter disease

A Novel Compound Heterozygous Mutation in AARS2 Gene (c.965 G > A, P.r322h; C.334 G > C, P.g112r) Identified in a Chinese Patient with Leukodystrophy Involved in Brain and Spinal Cord

Correction for Li and Guan, “human Mitochondrial Leucyl-tRNA Synthetase Corrects Mitochondrial Dysfunctions Due to the Trnaleu(uur) A3243G Mutation, Associated with Mitochondrial Encephalomyopathy, Lactic Acidosis, and Stroke-Like Symptoms and Diabetes”

[Mutations in Aminoacyl-Trna Synthetase Genes: an Analysis of 10 Cases].

An Adolescence-Onset Male Leukoencephalopathy with Remarkable Cerebellar Atrophy and Novel Compound Heterozygous AARS2 Gene Mutations: a Case Report

Alanyl-tRNA Synthetase 1 Gene Variants in Hereditary Neuropathy: Genotype and Phenotype Overview

A Pair of Compound Heterozygous IARS2 Variants Manifesting West Syndrome and Electrolyte Disorders in a Chinese Patient

Neonatal lactic acidosis explained by LARS2 defect

Aminoacyl-tRNA synthetase deficiencies in search of common themes

Treatment of ARS deficiencies with specific amino acids

Alanyl-transfer ribonucleic acid synthetase 2 gene mutation producing leukodystrophy: a case report

Biallelic mutations in valyl-tRNA synthetase gene VARS are associated with a progressive neurodevelopmental epileptic encephalopathy

Expanded clinical phenotype and untargeted metabolomics analysis in RARS2-related mitochondrial disorder: a case report

Four pedigrees with aminoacyl-tRNA synthetase abnormalities

MRI in LARS1 deficiency-Spectrum, patterns, and correlation with acute neurological deterioration

AARS2 Compound Heterozygous Variants in a Case of Adult-Onset Leukoencephalopathy with Axonal Spheroids and Pigmented Glia.

A non-coding variant in the Kozak sequence of RARS2 strongly decreases protein levels and causes pontocerebellar hypoplasia